Related Experiment Video

Updated: May 6, 2026

Comparative Lesions Analysis Through a Targeted Sequencing Approach
08:16

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Published on: November 5, 2019

6.2K

MAPK kinase 3 is a tumor suppressor with reduced copy number in breast cancer

Adam J MacNeil1, Shun-Chang Jiao, Lori A McEachern

  • 1Authors' Affiliations: Departments of Microbiology and Immunology, Pediatrics, Physiology and Biophysics, and Pathology, Dalhousie University; Beatrice Hunter Cancer Research Institute, Halifax, Nova Scotia, Canada; Department of Medical Oncology, General Hospital of the People's Liberation Army, Beijing; and Institute of Zoonosis, College of Animal Sciences and Veterinary Medicine, Jilin University, Changchun, Jilin, China.

Cancer Research
|November 16, 2013
PubMed

Insights

Mitogen-activated protein kinase (MAPK) MKK3 acts as a tumor suppressor in breast cancer. Loss of MKK3 gene copy number impairs its expression and promotes tumor growth by affecting cell-cycle arrest.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Cancer development involves genomic alterations affecting tumor-suppressor genes and oncogenes.
  • The mitogen-activated protein kinase (MAPK) pathway plays a dynamic role in tumor progression.

Purpose of the Study:

  • To investigate the role of mitogen-activated protein kinase kinase 3 (MKK3) in breast cancer growth.
  • To determine the functional significance of MKK3 copy number variations in breast cancer.

Main Methods:

  • Analysis of MKK3 gene copy number in breast cancer patients.
  • Assessment of MKK3 expression and protein levels in malignant tissues.
  • In vivo studies using an animal model to evaluate MKK3's effect on tumor growth.

Main Results:

  • MKK3 gene copy number loss is prevalent in breast cancer patients and correlates with reduced MKK3 expression.
  • MKK3 activity is essential for suppressing tumor growth in a preclinical model.
  • Active MKK3 upregulates cyclin-dependent kinase inhibitors p21(Cip1/Waf1) and p27(Kip1), inducing G1 cell-cycle arrest.

Conclusions:

  • MKK3 functions as a tumor suppressor in breast cancer.
  • Genomic alterations in MKK3 impact its tumor-suppressive function, influencing cell-cycle regulation and tumor progression.

More Related Videos

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

19.0K
Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment11:13

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

2.3K

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.0K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

1.8K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.3K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K